Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Chakrabarty, Hongmei Wang, L. Canaff, G. Hendy, H. Appelman, J. Varani (2005)
Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3).Cancer research, 65 2
E. Mokady, B. Schwartz, Shraga Shany, Lamprecht Sa (2000)
A Protective Role of Dietary Vitamin D3 in Rat Colon CarcinogenesisNutrition and Cancer, 38
Guangming Liu, Xin Hu, S. Chakrabarty (2010)
Vitamin D mediates its action in human colon carcinoma cells in a calcium‐sensing receptor‐dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5‐FUInternational Journal of Cancer, 126
S. Chakrabarty, V. Radjendirane, H. Appelman, J. Varani (2003)
Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation.Cancer research, 63 1
Yu-Chun Huang, Jing-yi Chen, W. Hung (2004)
Vitamin D3 receptor/Sp1 complex is required for the induction of p27Kip1 expression by vitamin D3Oncogene, 23
T. Halgren, R. Murphy, R. Friesner, Hege Beard, L. Frye, W. Pollard, J. Banks (2004)
Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.Journal of medicinal chemistry, 47 7
M. Milczarek, Sara Rosińska, Mateusz Psurski, M. Maciejewska, A. Kutner, J. Wietrzyk (2013)
Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin.Anticancer research, 33 2
A. Siwińska, A. Opolski, A. Chrobak, J. Wietrzyk, E. Wojdat, A. Kutner, W. Szelejewski, C. Radzikowski (2001)
Potentiation of the antiproliferative effect in vitro of doxorubicin, cisplatin and genistein by new analogues of vitamin D.Anticancer research, 21 3B
R. Xu, M. Lambert, B. Wisely, E. Warren, Emily Weinert, G. Waitt, Jon Williams, J. Collins, L. Moore, T. Willson, John Moore (2004)
A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer.Molecular cell, 16 6
Tingjun Hou, Junmei Wang, Youyong Li, Wei Wang (2011)
Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics SimulationsJournal of chemical information and modeling, 51 1
S. Lowe, S. Bodis, A. McClatchey, L. Remington, H. Ruley, D. Fisher, D. Housman, T. Jacks (1994)
p53 status and the efficacy of cancer therapy in vivo.Science, 266 5186
D. Matusiak, G. Murillo, R. Carroll, R. Mehta, R. Benya (2005)
Expression of Vitamin D Receptor and 25-Hydroxyvitamin D3-1α-Hydroxylase in Normal and Malignant Human ColonCancer Epidemiology Biomarkers & Prevention, 14
L. Berkovich, A. Sintov, S. Ben-Shabat (2013)
Erratum to: Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studiesInvestigational New Drugs, 31
D. Longley, D. Harkin, P. Johnston (2003)
5-Fluorouracil: mechanisms of action and clinical strategiesNature Reviews Cancer, 3
R. Friesner, R. Murphy, Matthew Repasky, L. Frye, J. Greenwood, T. Halgren, P. Sanschagrin, Daniel Mainz (2006)
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.Journal of medicinal chemistry, 49 21
G. Peters, C. Wilt, C. Moorsel, J. Kroep, A. Bergman, S. Ackland (2000)
Basis for effective combination cancer chemotherapy with antimetabolites.Pharmacology & therapeutics, 87 2-3
G. Díaz, C. Paraskeva, Michael Thomas, L. Binderup, A. Hague (2000)
Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.Cancer research, 60 8
Manish Shah, G. Schwartz (2001)
Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 8
Xi Zhao, David Feldman (1993)
Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.Endocrinology, 132 4
(2004)
Francis P and Shenkin PS: Glide: a new approach for rapid, accurate docking and scoring
H. Pálmer, J. González-Sancho, J. Espada, M. Berciano, I. Puig, J. Baulida, M. Quintanilla, A. Cano, A. Herreros, M. Lafarga, A. Muñoz (2001)
Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signalingThe Journal of Cell Biology, 154
Tocchini-Valentini (2004)
Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and secocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modificationJ Med Chem, 47
Tingjun Hou, Junmei Wang, Youyong Li, Wei Wang (2011)
Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from dockingJournal of Computational Chemistry, 32
K. Takagi, Y. Sowa, Ozgur Cevik, Ryoko Nakanishi, T. Sakai (2008)
CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells.International journal of oncology, 32 5
G. Sastry, Matvey Adzhigirey, T. Day, R. Annabhimoju, W. Sherman (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichmentsJournal of Computer-Aided Molecular Design, 27
R. Koren, Shiri Wacksberg, G. Weitsman, A. Ravid (2006)
Calcitriol sensitizes colon cancer cells to H2O2-induced cytotoxicity while inhibiting caspase activationThe Journal of Steroid Biochemistry and Molecular Biology, 101
M. Grau, J. Baron, R. Sandler, R. Haile, M. Beach, T. Church, D. Heber (2003)
Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial.Journal of the National Cancer Institute, 95 23
A. Sutton, P. MacDonald (2003)
Vitamin D: more than a "bone-a-fide" hormone.Molecular endocrinology, 17 5
N. Bhagavathula, Andrew Hanosh, Kamalakar Nerusu, H. Appelman, S. Chakrabarty, J. Varani (2007)
Regulation of E‐cadherin and β‐catenin by Ca2+ in colon carcinoma is dependent on calcium‐sensing receptor expression and functionInternational Journal of Cancer, 121
J. Abe-Hashimoto, T. Kikuchi, T. Matsumoto, Y. Nishii, E. Ogata, K. Ikeda (1993)
Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen.Cancer research, 53 11
R. Bouillon, K. Allewaert, D. Xiang, B. Tan, H. Baelen (1991)
Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activityJournal of Bone and Mineral Research, 6
J. Wietrzyk, M. Pełczyńska, J. Madej, S. Dzimira, H. Kuśnierczyk, A. Kutner, W. Szelejewski, A. Opolski (2004)
Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191)Steroids, 69
J. Wietrzyk, A. Opolski, J. Madej, C. Radzikowski (2000)
Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.In vivo, 14 2
Motoki Watanabe, Y. Sowa, Mayumi Yogosawa, T. Sakai (2013)
Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)‐reactivating agents enhance efficacy of 5‐fluorouracil on human colon cancer cellsCancer Science, 104
M. Milczarek, Mateusz Psurski, A. Kutner, J. Wietrzyk (2013)
Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer modelBMC Cancer, 13
P. Stambolsky, Y. Tabach, G. Fontemaggi, L. Weisz, Revital Maor-Aloni, Z. Siegfried, Idit Shiff, I. Kogan, M. Shay, Eyal Kalo, G. Blandino, I. Simon, M. Oren, V. Rotter (2010)
Modulation of the vitamin D3 response by cancer-associated mutant p53.Cancer cell, 17 3
R. Pritchard, J. Baron, M. Verdier (1996)
Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 5 11
Anna Saramäki, C. Banwell, M. Campbell, C. Carlberg (2006)
Regulation of the human p 21 ( waf 1 / cip 1 ) gene promoter via multiple binding sites for p 53 and the vitamin D 3 receptor
Spina (2006)
Vitamin D and cancerAnticancer Res, 26
T. Hartman, P. Albert, Kirk Snyder, M. Slattery, B. Caan, E. Paskett, F. Iber, J. Kikendall, J. Marshall, M. Shike, J. Weissfeld, B. Brewer, A. Schatzkin, E. Lanza (2005)
The association of calcium and vitamin D with risk of colorectal adenomas.The Journal of nutrition, 135 2
Jin Meng, Hai-Hua Zhang, Chun Zhou, Chen Li, Feng Zhang, Q. Mei (2012)
The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.Oncology reports, 28 1
R. Kim, M. Emi, K. Tanabe, Y. Uchida, K. Arihiro (2006)
The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 32 3
Anna Saramäki, C. Banwell, M. Campbell, C. Carlberg (2006)
Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptorNucleic Acids Research, 34
P. Terry, J. Baron, L. Bergkvist, L. Holmberg, A. Wolk (2002)
Dietary Calcium and Vitamin D Intake and Risk of Colorectal Cancer: A Prospective Cohort Study in WomenNutrition and Cancer, 43
A. Baniahmad, M. Tsai (1993)
Mechanisms of transcriptional activation by steroid hormone receptorsJournal of Cellular Biochemistry, 51
Jianing Li, Robert Abel, Kai Zhu, Yixiang Cao, Suwen Zhao, R. Friesner (2011)
The VSGB 2.0 model: A next generation energy model for high resolution protein structure modelingProteins: Structure, 79
M. Larriba, P. Ordóñez-Morán, I. Chicote, G. Martín-Fernández, I. Puig, A. Muñoz, H. Pálmer (2011)
Vitamin D Receptor Deficiency Enhances Wnt/β-Catenin Signaling and Tumor Burden in Colon CancerPLoS ONE, 6
J. Wietrzyk, M. Chodyński, H. Fitak, E. Wojdat, A. Kutner, A. Opolski (2007)
Antitumor properties of diastereomeric and geometric analogs of vitamin D3Anti-Cancer Drugs, 18
Xiao-Xin Sun, M. Dai, Hua Lu (2007)
5-Fluorouracil Activation of p53 Involves an MDM2-Ribosomal Protein Interaction*Journal of Biological Chemistry, 282
(2014)
ONCOLOGY REPORTS
Xize Wang, Wei Chen, Navneet Singh, Multira Promkan, Guangming Liu (2010)
Effects of potential calcium sensing receptor inducers on promoting chemosensitivity of human colon carcinoma cells.International journal of oncology, 36 6
Doris Hummel, U. Thiem, J. Höbaus, I. Mesteri, L. Gober, C. Stremnitzer, João Graç, B. Obermayer‐Pietsch, E. Kallay
Journal of Steroid Biochemistry and Molecular Biology Prevention of Preneoplastic Lesions by Dietary Vitamin D in a Mouse Model of Colorectal Carcinogenesis
M. Chodyński, J. Wietrzyk, E. Marcinkowska, A. Opolski, W. Szelejewski, A. Kutner (2002)
Synthesis and antiproliferative activity of side-chain unsaturated and homologated analogs of 1,25-dihydroxyvitamin D2 (24E)-(1S)-24-Dehydro-24a-homo-1,25-dihydroxyergocalciferol and congenersSteroids, 67
J. Abe, Toshiaki Nakano, Y. Nishii, T. Matsumoto, Etsuro Ogata, Kyoji Ikeda (1991)
A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.Endocrinology, 129 2
Hummel (2013)
Prevention of preneoplastic lesions by dietary vitamin D in a mouse model of colorectal carcinogenesisJ Steroid Biochem Mol Biol, 136
L. Vuolo, C. Somma, A. Faggiano, A. Colao (2012)
Vitamin D and CancerFrontiers in Endocrinology, 3
J. Wietrzyk, Dmitry Nevozhay, M. Milczarek, B. Filip, A. Kutner (2008)
Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer modelCancer Chemotherapy and Pharmacology, 62
M. Pełczyńska, M. Świtalska, M. Maciejewska, Iwona Jaroszewicz, A. Kutner, A. Opolski (2006)
Antiproliferative activity of vitamin D compounds in combination with cytostatics.Anticancer research, 26 4A
Silvia Álvarez-Díaz, Noelia Valle, Gemma Ferrer-Mayorga, L. Lombardía, M. Herrera, O. Domínguez, M. Segura, F. Bonilla, E. Hernando, A. Muñoz (2012)
MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.Human molecular genetics, 21 10
Robert Mader, Markus Müller, Günther Steger (1998)
Resistance to 5-fluorouracil.General pharmacology, 31 5
A. Moreau, P. Maurel, M. Vilarem, J. Pascussi (2007)
Constitutive androstane receptor-vitamin D receptor crosstalk: consequence on CYP24 gene expression.Biochemical and biophysical research communications, 360 1
S. Lamprecht, M. Lipkin (2003)
Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanismsNature Reviews Cancer, 3
Hsuen-Tsen Cheng, Jing-yi Chen, Yu-Chun Huang, Hui‐Chiu Chang, W. Hung (2006)
Functional role of VDR in the activation of p27Kip1 by the VDR/Sp1 complexJournal of Cellular Biochemistry, 98
J. Wietrzyk, Dmitry Nevozhay, B. Filip, M. Milczarek, A. Kutner (2007)
The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.Anticancer research, 27 5A
G. Rastelli, A. Rio, G. Degliesposti, M. Sgobba (2009)
Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSAJournal of Computational Chemistry, 31
A. Hidalgo, R. Paredes, V. García, Geraldine Flynn, Candace Johnson, D. Trump, S. Oñate (2007)
Altered VDR-mediated transcriptional activity in prostate cancer stromaThe Journal of Steroid Biochemistry and Molecular Biology, 103
A. Ravid, Dafna Rocker, A. Machlenkin, C. Rotem, A. Hochman, G. Kessler‐Icekson, U. Liberman, R. Koren (1999)
1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage.Cancer research, 59 4
R. Friesner, J. Banks, R. Murphy, T. Halgren, Jasna Klicic, Daniel Mainz, Matthew Repasky, E. Knoll, Mee Shelley, J. Perry, D. Shaw, Perry Francis, P. Shenkin (2004)
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.Journal of medicinal chemistry, 47 7
B. Kota, J. Allen, B. Roufogalis (2011)
The effect of vitamin D3 and ketoconazole combination on VDR-mediated P-gp expression and function in human colon adenocarcinoma cells: implications in drug disposition and resistance.Basic & clinical pharmacology & toxicology, 109 2
Baojian Wu, Sha Li, Dong Dong (2013)
3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR.Drug discovery today, 18 11-12
P. Stambolsky, Y. Tabach, G. Fontemaggi, L. Weisz, Revital Maor-Aloni, Zahava Sigfried, Idit Shiff, I. Kogan, M. Shay, Eyal Kalo, G. Blandino, I. Simon, M. Oren, V. Rotter
Modulation of the Vitamin D 3 Response by Cancer-Associated Mutant p 53
M. Danilenko, G. Studzinski (2004)
Enhancement by other compounds of the anti-cancer activity of vitamin D(3) and its analogs.Experimental cell research, 298 2
R. Xu, M. Lambert, B. Wisely, E. Warren, Emily Weinert, G. Waitt, Jon Williams, J. Collins, L. Moore, T. Willson, John Moore (2004)
A Structural Basis for Constitutive Activity in the Human CAR/RXRα HeterodimerMolecular Cell, 16
T. Gaschott, Oliver Werz, Andreas Steinmeyer, D. Steinhilber, Jürgen Stein (2001)
Butyrate-induced differentiation of Caco-2 cells is mediated by vitamin D receptor.Biochemical and biophysical research communications, 288 3
Y. Cho, C. Christensen, D. Saunders, W. Lawrence, M. Deppe, V. Malviya, J. Malone (1991)
Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells.Cancer research, 51 11
A. Opolski, J. Wietrzyk, A. Siwińska, E. Marcinkowska, A. Chrobak, C. Radzikowski, A. Kutner (2000)
Biological activity in vitro of side-chain modified analogues of calcitriol.Current pharmaceutical design, 6 7
A. Sintov, L. Berkovich, S. Ben-Shabat (2013)
Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studiesInvestigational New Drugs, 31
S. Nagpal, S. Na, Radhakrishnan Rathnachalam (2005)
Noncalcemic actions of vitamin D receptor ligands.Endocrine reviews, 26 5
T. Matsunaga, Masaru Yamamoto, H. Mimura, T. Ohta, M. Kiyoki, T. Ohba, T. Naruchi, J. Hosoi, Toshio Kuroki (1990)
1,24(R)‐Dihydroxyvitamin D3, a Novel Active Form of Vitamin D3 with High Activity for Inducing Epidermal Differentiation but Decreased Hypercalcemic ActivityThe Journal of Dermatology, 17
V. Tangpricha, C. Spina, M. Yao, Tai Chen, M. Wolfe, M. Holick (2005)
Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice.The Journal of nutrition, 135 10
Tanya McCarthy, Xiufeng Li, C. Sinal (2005)
Vitamin D Receptor-dependent Regulation of Colon Multidrug Resistance-associated Protein 3 Gene Expression by Bile Acids*Journal of Biological Chemistry, 280
In the present study, we evaluated the antitumor effect of two synthetic analogs of vitamin D, namely PRI-2191 ((24R)-1,24-dihydroxyvitamin D3) and PRI-2205 (5,6-trans calcipotriol), in combined human colon HT-29 cancer treatment with 5-fluorouracil (5-FU). Mice bearing HT-29 tumors transplanted subcutaneously or orthotopically were injected with vitamin D analogs and 5-FU in various schedules. A statistically significant inhibition of subcutaneous or orthotopic tumor growth was observed as a result of combined therapy. In HT-29 tumors and in cells from in vitro culture, we observed increased vitamin D receptor (VDR) expression after treatment with either PRI-2205 or 5-FU alone, or in combination. Moreover, PRI-2205 decreased the percentage of cells from intestinal tumors in G2/M and S stages and increased sub-G1. Increased VDR expression was also observed after combined treatment of mice with 5-FU and PRI-2191. Moreover, our docking studies showed that PRI-2205 has stronger affinity for VDR, DBP and CAR/RXR ligand binding domains than PRI-2191. PRI-2191 analog, used with 5-FU, increased the percentage of subcutaneous tumor cells in G0/G1 and decreased the percentage in G2/M, S and sub-G1 populations as compared to 5-FU alone. In in vitro studies, we observed increased expression of p21 and p-ERK1/2 diminution via use of both analogs as compared to use of 5-FU alone. Simultaneously, PRI-2191 antagonizes some pro-apoptotic activities of 5-FU in vitro. However, in spite of these disadvantageous effects in terms of apoptosis, the therapeutic effect expressed as tumor growth retardation by PRI-2191 is significant. Our results suggest that the mechanism of potentiation of 5-FU antitumor action by both analogs is realized via increased p21 expression and decreased p-ERK1/2 level which may lead to diminution of thymidylate synthase expression. Higher binding affinity for VDR, DBP, but also for CAR\RXR ligand binding domain of PRI-2205 may, in part, explain its very low toxicity with sustained anticancer activity.
Oncology Reports – Spandidos Publications
Published: Aug 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.